CLINICAL_TRIALS
trial_result
· 2024-12-09
Clinical Trial Update: Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis [Phase 2]
Summary
This document reports Phase 2 trial results for ranolazine in amyotrophic lateral sclerosis, focusing on safety and efficacy, with the study now completed and r…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Kansas Medical Center | Conditions: ALS | Phase 2 | Status: COMPLETED | Results posted: 2024-12-09